GHAM
BHVN

Gilman Hill Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Gilman Hill Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,500
Closed -$207K – 228
2021
Q4 		$207K Hold
1,500
– – 0.05% 212
2021
Q3 		$208K Buy
+1,500
New +$208K 0.05% 194